NCT05171283View on ClinicalTrials.gov

Meta-analysis of Oat Fiber and Cardiovascular Risk Reduction

Active, not recruitingOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

May 30, 2024

Study Completion Date

December 1, 2024

Conditions
Cardiovascular DiseasesCoronary Heart Disease
Interventions
OTHER

Oats or Oat Fibre

Interventions that contain whole grain oats or oat beta-glucan.

Trial Locations (1)

M5C 2T2

The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Quaker Oats Centre of Excellence, Quaker

UNKNOWN

lead

University of Toronto

OTHER